Conference Track

Metabolic Complications and Adverse Events

Source: CCO Independent Conference Coverage of the 2007 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Capsule Summaries

Alendronate Treatment Associated With Significant Bone Mineral Density Increase in ACTG A5163 Study
Lopinavir/Ritonavir Maintenance Monotherapy Associated With Less Peripheral Lipoatrophy Than Efavirenz + Zidovudine/Lamivudine in Treatment-Naive Patients
ALLRT: Viral Suppression Following HAART Initiation Associated With Improved Renal Function in Patients With Renal Impairment and Advanced HIV Disease
Regimens Containing Tenofovir and NNRTI Associated With Comparable Decreases in Renal Function to Regimens Without Tenofovir
Not Initiating ART Associated More Strongly to Increased CVD Events Than ART Treatment Interruption Strategy
Low Bone Mineral Density Significantly More Prevalent in HIV-Infected Population Than HIV-Uninfected Population
ACTG 5142: Efavirenz Plus NRTIs Associated With Greater Incidence of Lipoatrophy Than Lopinavir/Ritonavir Plus NRTIs
Pooled Subgroup Analysis Finds Tenofovir-Containing Regimens Have Greater Efficacy Than Thymidine Analogue Regimens in Black Patients
HIV-Infected Patients Show Reduced Response to Lipid-Lowering Drugs vs Uninfected Patients
Dietary Fat Intake Associated With Dyslipidemia in HIV-Infected Individuals
D:A:D Subanalysis Finds Most but Not All HIV Patients With Cardiovascular Events Initiate Lipid-Lowering Drugs
TH9507 Improves Abdominal Fat Gain Without Growth Hormone Adverse Effects
Increased Carotid Intima-Media Thickness Observed in HIV-Infected Patients vs HIV-Negative Controls

Expert Analysis

Metabolic Complications and Adverse Events of HIV and Antiretroviral Therapy

Faculty:
Judith S. Currier, MD, MSc Sally Hodder, MD Donald P. Kotler, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the metabolic results of the AIDS Clinical Trials Group 5142 study
Describe dietary fat intake of HIV-infected patients
List results of a trial of alendronate in patients with osteopenia

CME CREDIT INFORMATION

Release Date: 05/15/07

Expiration Date: 05/14/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.2 contact hours (0.12 CEUs)

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.